INVIVYD INC. - COMMON

0.9033

08-October-24 12:22:55

15 minutes delayed

Stocks

-0.0180

-1.95%

Today's range

0.9000 - 0.9686

ISIN

N/A

Source

NASDAQ

Adagio Therapeutics Provides Update for ADG20 COVID-19 Antibody Program and Reports Third Quarter 2021 Financial Results

15 Nov 2021 06:30:00 By Nasdaq GlobeNewswire
Adagio Therapeutics to Participate in Upcoming Investor Conferences

10 Nov 2021 06:30:00 By Nasdaq GlobeNewswire
Adagio Therapeutics Announces New In Vitro Data Highlighting Broad and Potent Neutralization of ADG20 Against All Known SARS-CoV-2 Variants

19 Oct 2021 06:30:00 By Nasdaq GlobeNewswire
Adagio Therapeutics Announces New Data Highlighting the Potential of ADG20 for Treatment and Prevention of COVID-19

29 Sep 2021 06:30:00 By Nasdaq GlobeNewswire
Adagio Therapeutics to Participate in the Guggenheim 2nd Annual Vaccines & Infectious Day Conference

29 Sep 2021 06:30:00 By Nasdaq GlobeNewswire

<<
<
1
2
3
4
5
>

I Agree NetDania's website uses cookies. By continuing browsing our website, you agree to our Cookie Policy, Privacy Policy and Terms and Conditons.